Loading...
Loading...
Trademark Dashboard – UK Trademark Search & ClearanceApplication UK00000322533 · Dead
| Application Number | UK00000322533 |
| Status | Dead |
| Owner | sanofi-aventis |
| Filed | 1910-04-11 |
| Registered | 1910-04-11 |
| Renewal Due | 2008-04-11 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
EUMYDRIN has a current status of Dead.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
A pharmaceutical product for human use.
'EUMYDRIN' is a dead trademark on the UK IPO register, owned by sanofi-aventis. The application (UK00000322533) was filed on 11 April 1910 and registered on 11 April 1910. The registration is set to expire on 11 April 2008.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by Mishcon de Reya LLP.
According to the UK IPO register, 'EUMYDRIN' is owned by sanofi-aventis.
No — the UK IPO records the status of 'EUMYDRIN' as dead.
'EUMYDRIN' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: A pharmaceutical product for human use.
The application for 'EUMYDRIN' was filed on 11 April 1910 and the trademark was registered on 11 April 1910.
The UK IPO first published / advertised 'EUMYDRIN' on 25 May 1910.
The current registration of 'EUMYDRIN' is recorded as valid until 11 April 2008, at which point it will need to be renewed to remain in force.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.